WOLF SZMUNESS, M.D.; JULES L. DIENSTAG, M.D.; ROBERT H. PURCELL, M.D.; ALFRED M. PRINCE, M.D.; CLADD E. STEVENS, M.D.; RICHARD W. LEVINE
Four hundred sixty patients and staff from 15 U.S. dialysis centers were surveyed by the immune adherence hemagglutination technique for antibody to hepatitis A antigen (anti-HA). The age-standardized anti-HA prevalence was 42.9% in patients and 42.1% in staff. These rates are almost identical to those of socioeconomically comparable urban volunteer blood donors never exposed to dialysis settings. There was no correlation between anti-HA prevalences and duration of dialysis treatment or employment. Among 100 patients and staff followed for 1 year 92% to 94% did not change their anti-HA status. The prevalence of anti-HA was identical in subjects with past histories of multiple blood transfusions or accidental inoculations with blood-contaminated instruments and in those without such histories. We conclude that hepatitis A virus rarely if ever spreads by parenteral mechanisms, that there is no epidemiologic evidence confirming the existence of chronic hepatitis A viremic carrier states, and that hemodialysis does not play a significant role in the spread of type A hepatitis.
SZMUNESS W, DIENSTAG JL, PURCELL RH, PRINCE AM, STEVENS CE, LEVINE RW. Hepatitis Type A and Hemodialysis: A Seroepidemiologic Study in 15 U.S. Centers. Ann Intern Med. ;87:8–12. doi: 10.7326/0003-4819-87-1-8
Download citation file:
© 2019
Published: Ann Intern Med. 1977;87(1):8-12.
DOI: 10.7326/0003-4819-87-1-8
Gastroenterology/Hepatology, Infectious Disease, Liver Disease, Nephrology, Renal Replacement Therapy.
Results provided by: